Related Experiment Videos
[The surgeon's procedure in acute esophagogastroduodenal hemorrhage]
Klinicheskaia Khirurgiia
|January 1, 1993
Insights
This study analyzed 639 patients with acute esophagogastroduodenal bleeding, finding ulcer disease as the primary cause. Treatment outcomes revealed complications in 24.9% and an 8.6% mortality rate.
Area of Science:
- Gastroenterology
- Internal Medicine
- Surgical Gastroenterology
Context:
- Acute esophagogastroduodenal bleeding is a significant clinical challenge.
- Understanding the etiological spectrum and treatment outcomes is crucial for patient management.
Purpose:
- To analyze the causes, treatment modalities, and outcomes of acute esophagogastroduodenal bleeding in a large patient cohort.
- To identify factors influencing complications and mortality.
Summary:
- A retrospective analysis of 639 patients with acute esophagogastroduodenal bleeding was conducted.
- The most common cause identified was ulcer disease (66.4%), followed by gastric tumors (9.1%), erosive gastritis (7.3%), and portal hypertension (6.4%).
- Conservative treatment was employed in 59% of patients, while 41% underwent surgery. Complications occurred in 24.9% of patients, with an overall mortality rate of 8.6%.
Impact:
- Findings highlight the predominant role of ulcer disease in acute upper gastrointestinal bleeding.
- The study underscores the need for effective management strategies to reduce morbidity and mortality associated with this condition.
- Results provide valuable data for clinical decision-making and resource allocation in managing gastrointestinal bleeding emergencies.
Abstract:
The results of treatment of 639 patients with acute esophagogastroduodenal bleeding have been analysed. There were the following causes of bleeding: in 66.4%--ulcer disease, in 9.1%--gastric tumours, in 7.3%--erosive gastritis, in 6.4%--portal hypertension, in 9.1%--the other. In 1.7% of patients, a cause was not established. Conservative treatment was performed in 59% of patients, surgery--in 41%. Complications developed in 24.9% of the patients, 8.6% died.